References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | K2 Transfection System | application note | ||||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | B. Li et al., ResearchSquare, 2020, doi.org/10.21203/rs.3.rs-58864/v1 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | application note | ||||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., Jul 2015; 290: 17894 - 17908 | ||
U343 |
Human malignant astrocytoma cell line | Human | brain | cell line | plasmid | Metafectene | publication | V. Voss et al., Mol. Cancer Res., Jul 2010; 8: 1002 - 1016 | Link | ||||
U2OS 2-6-3 |
Human bone osteosarcoma cell line (derivat of U2OS) | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS 2-6-3 |
Human bone osteosarcoma cell line (derivat of U2OS) | Human | bone | cell line | adherent | plasmid | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | |||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. M. Davies, PhD Thesis, 2015, University of Dundee | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. I. Sheikh et al., Translat. Psychiatry, 2021,1 1:1, doi.org/10.1038/s41398-020-01158-w | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene PRO | publication | J. Suchánková et al., Europ. J. of Histochemistry, 2014; 58:2389, doi:10.4081/ejh.2014.2389 | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Martin et al., Oncogene, 2015, 34:1058-1063; doi:10.1038/onc.2014.38 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 | |||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Hernández-Pérez et al., Oncogene, 2017, 36: 4802 4809, doi:10.1038/onc.2017.21 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Hernández-Pérez et al., Oncogene, 2017, 36: 4802-4809, doi:10.1038/onc.2017.21 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz et al., Hum. Mol. Genet., Dec 2016, DOI: 10.1093/hmg/ddw364 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | Y. Martin et al., Oncogene, 2015, 34:1058-1063; doi:10.1038/onc.2014.38 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Di Maio et al., FEBS Open Bio, 2017, 7: 1453-1468, doi:10.1002/2211-5463.12307 | Link |